Prime Therapeutics Initiative Aims to Help Plan Sponsors Pay for Gene Therapies
The new PreserveRx program from Prime Therapeutics looks to help plan sponsors deal with high-cost gene therapies, Fierce Healthcare reports. [...]
Report: BCBS of Michigan Paying Workers to Join COVID-19 Fight
In an effort to ramp up the fight against the COVID-19 pandemic, Blue Cross Blue Shield of Michigan is offering [...]
Fauci: Trump ‘Does Listen’
Anthony Fauci, the nation's top coronavirus expert, told JAMA in a recent interview that while President Donald Trump sometimes says [...]
Adaptive Trial Uses AI to Pinpoint Top COVID-19 Treatments
The REMAP-CAP trial is implementing artificial intelligence in a bid to rapidly identify the best possible treatments for COVID-19 patients, [...]
HealthEconomics.Com, Scientist.Com Announce HEOR, RWE Partnership
HealthEconomics.Com© LLC and Scientist.Com are partnering to streamline HEOR and real-world evidence sourcing in the global HEOR and RWE community [...]
Panel Talks Democratization of Patient Data Ownership
A panel during the 6th Patients as Partners U.S. conference discussed why the democratization of patient data is a disruptive [...]
Bricker Talks Wave 2 of COVID-19
How can payers and providers best prepare for a second wave in the COVID-19 pandemic? Compass Professional Health Services CMO [...]
Podcast Dives Into Cost-Sharing Provision of CARES Act
Attorney Doug Aldeen and Quizzify Founder Al Lewis in a Relentless Health Value podcast discuss a cost-sharing provision contained in [...]
What Can ICER Learn from Big Tech Companies?
The Institute for Clinical and Economic Review's (ICER) reputation has seen significant growth, but the author of a recent article [...]
Fein Highlights CMS Spending Report
Drug Channels Institute CEO Adam Fein in a recent blog post writes that the latest forecast for National Health Expenditures [...]
Blog Post Highlights Impact Coronavirus Could Have on New Drug Launches
A recent blog post on Tribeca Knowledge outlines some of the key challenges pharmaceutical companies face regarding drug launches in [...]
RTI Acquires Medical Data Analytics
RTI International recently announced the acquisition of Medical Data Analytics (MDA), an addition that is expected to bolster RTI Health [...]
Coronavirus Patients Look to New Gilead Drug
As the world rushes to find a treatment for COVID-19, coronavirus patients are looking to secure a spot in studies [...]
Shkreli Seeks Furlough to Research Potential COVID-19 Treatments
Disgraced biotech entrepreneur Martin Shkreli is requesting a 3-month furlough to research potential treatments for COVID-19, STAT reports. In a [...]
ISPOR 2020 Goes Virtual
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is moving its annual meeting into the virtual space in response [...]
MJH Bolsters Managed Care Position with PBMI Acquisition
MJH Life Sciences says its acquisition of Pharmacy Benefit Management Institute (PBMI) will bolster its position in the managed care [...]
AMCP to Supreme Court: Ruling Against PCMA Could Raise Health Costs
The Academy of Managed Care Pharmacy (AMCP) in an amicus brief filed in the Supreme Court tells the court ruling [...]
Article: ICER’s Judgements ‘Anchored by Cost-Effectiveness’
The authors of a recent article suggest that Institute for Clinical and Economic Review (ICER) council members' judgements are ultimately [...]
Oracle Founder Looks to Partner with White House to Combat Coronavirus
Oracle Founder Larry Ellison is working with the Trump White House in a bid to use big data in the [...]
MedComms Workbook Aims to Help Freelancers
The MedComms Workbook, an online service managed by NetworkPharma, looks to connect clients with specialist freelancers. "The MedComms Workbook helps [...]
MSK’s Bach Talks High-Value Drug Development
Memorial Sloan Kettering Cancer Center's Dr. Peter Bach in a recent interview with Liam Bendicksen discusses ways to optimize high-value [...]
Looking Back at the Formulary System in 1997
AMCP Fellow Steven Avey in a recent article published in JMCP goes back to 1997 to look at how the [...]
ISPOR Task Force Publishes New Good Practices Reports
The International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) Value of Information Analysis Emerging Good Practices Task Force has had [...]
2bPrecise CMO: Precision Medicine ‘Appears to be an Unstoppable Force’
Precision medicine could "revolutionize" the diagnoses and treatment of patients, 2bPrecise Chief Medical Officer Joel Diamond writes in a recent [...]
McKesson’s Alwardt: RWE Should Be Part of Oncological Clinical Trials
Sarah Alwardt, McKesson's vice president of health informatics and HEOR, says companies should utilize historic real-world evidence in oncological clinical [...]